000 01793 a2200505 4500
005 20250511224243.0
264 0 _c19910313
008 199103s 0 0 eng d
022 _a0959-8049
024 7 _a10.1016/0277-5379(90)90613-x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBiesma, B
245 0 0 _aEfficacy and tolerability of recombinant human granulocyte-macrophage colony-stimulating factor in patients with chemotherapy-related leukopenia and fever.
_h[electronic resource]
260 _bEuropean journal of cancer (Oxford, England : 1990)
_c1990
300 _a932-6 p.
_bdigital
500 _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial
650 0 4 _aAdolescent
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAntineoplastic Agents
_xadverse effects
650 0 4 _aBone Marrow Transplantation
650 0 4 _aDouble-Blind Method
650 0 4 _aFemale
650 0 4 _aFever
_xdrug therapy
650 0 4 _aGranulocyte-Macrophage Colony-Stimulating Factor
_xtherapeutic use
650 0 4 _aHumans
650 0 4 _aInterleukin-6
_xmetabolism
650 0 4 _aLeukocyte Count
650 0 4 _aLeukopenia
_xblood
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aNeoplasms
_xdrug therapy
650 0 4 _aNeutrophils
650 0 4 _aRecombinant Proteins
_xtherapeutic use
650 0 4 _aTumor Necrosis Factor-alpha
_xmetabolism
700 1 _ade Vries, E G
700 1 _aWillemse, P H
700 1 _aSluiter, W J
700 1 _aPostmus, P E
700 1 _aLimburg, P C
700 1 _aStern, A C
700 1 _aVellenga, E
773 0 _tEuropean journal of cancer (Oxford, England : 1990)
_gvol. 26
_gno. 9
_gp. 932-6
856 4 0 _uhttps://doi.org/10.1016/0277-5379(90)90613-x
_zAvailable from publisher's website
999 _c2155163
_d2155163